Evaluation of Soft Tissue Healing and Implant Stability of Cochlear Baha BI300/BA400 Implant System Loaded From 1 Week Post-surgery After Linear Incision Without Soft Tissue Reduction.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 25
- 试验地点
- 2
- 主要终点
- Implant stability
研究概览
简要总结
Objectives
- To evaluate the safety of processor loading of the Cochlear BI300/BA400 implant system 1 week after implantation
- To evaluate the short term soft tissue healing and the long term skin reaction, with the new Cochlear BI300/BA400 implant system using the linear incision without subcutaneous tissue reduction.
- To produce reference data regarding the stability of the BI300/BA400 implant system.
Study design: Prospective cohort study. Patients: 24 adults with anticipated normal skin and bone quality eligible for bone anchored implant surgery.
Intervention: Loading of the sound processor one week after surgery Main outcome measures: Implant stability, soft tissue reaction, skin overgrowth, pain and numbness will be assessed.
It is hypothesized that implant loading can be performed one week after surgery without any changes in implant stability, soft tissue reaction, skin overgrowth, pain or numbness around implant.
详细描述
Background Implant stability
Until recently, the implants used in Baha surgery have exclusively been standard Brånemark type of titanium implants with an as-machined surface finish. The recommended procedure for Baha implantation with the machined titanium implants uses a 12-week healing period before loading the implant with a sound processor, in order to allow sufficient time for the implant to become integrated in the bone. The Cochlear Baha BI300 Series implant was designed to improve implant stability at placement and over time, thus making it possible to reduce the time to sound processor fitting. The implant features a wider diameter compared to the previous generation Baha implant, small-sized threads at the cylindrical portion of the implant underneath the flange, and a roughened implant surface due to formation of titanium oxide after blasting.
Six-month data from a multi-centre clinical investigation comparing the new implant with the previous generation Baha implant using a 6-week loading protocol, shows significantly higher Implant Stability Quotient (ISQ) values (measured by resonance frequency analysis) for the new implant at each time point, and no reduction in stability after loading (Dun et al., 2011). The data from the study suggest that the implant stability achieved 6 weeks after implantation is sufficient to support the sound processor. The data also suggest that a further reduction of the time to sound processor fitting may be possible, provided favourable bone conditions at the implant site and provided satisfactory soft tissue status at the time of loading. Hence, a clinical investigation with implant loading 21 days post-surgery was initiated by the team in Nijmegen, and 6-month data from the investigation confirm that it is safe to attach the sound processor after 3 weeks (Faber et al., 2012). Early results from two other studies using loading times of 4 weeks (McLarnon et al., 2012) and 2 weeks (Green et al., 2011), respectively, have also been presented and show good outcomes. All studies have been performed on patients with good bone quality.
Data from a prospective study with 49 patients loaded from 2 weeks post-surgery show no initial dip in stability and show no decrease in stability in the period after processor loading (ongoing study, awaiting publication). The stability of the implant in this study after one week is sufficient for processor loading at this time. No studies exist that investigates the effect on stability after processor loading 1 week postoperatively.
Implant stability measurement
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients ≥ 18 years of age, with normal intelligence.
- •Absence of previous radiotherapy to the implant area.
- •Absence of active skin disease in the implant area.
- •Absence of diabetes.
- •Absence of osteoporosis
- •Absence of any relevant medical history or current disease/treatment/medication that may affect bone or skin quality in the implant area.
排除标准
- •No further
结局指标
主要结局
Implant stability
时间窗: 12 months
See description for Implant stability, day of surgery Implant stability is assessed using resonance frequency analysis.
次要结局
- Skin overgrowth(12 months)
- Pain around implant(12 months)
- Numbness around implant(12 months)
- Soft tissue status(12 months)
研究者
Dr. Lars Vendelbo Johansen
Consultant
Aarhus University Hospital
